A detailed history of Tower Research Capital LLC (Trc) transactions in Eli Lilly & CO stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 20,259 shares of LLY stock, worth $16.1 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
20,259
Previous 28,016 27.69%
Holding current value
$16.1 Million
Previous $25.4 Million 29.24%
% of portfolio
0.49%
Previous 0.44%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $5.99 Million - $7.45 Million
-7,757 Reduced 27.69%
20,259 $17.9 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $5.55 Million - $6.96 Million
7,651 Added 37.57%
28,016 $25.4 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $51.7 Million - $69.1 Million
-87,258 Reduced 81.08%
20,365 $15.8 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $40 Million - $47.2 Million
76,160 Added 242.06%
107,623 $62.7 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $6.29 Million - $8.67 Million
14,467 Added 85.12%
31,463 $16.9 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $1.02 Million - $1.37 Million
2,920 Added 20.74%
16,996 $7.97 Million
Q1 2023

May 09, 2023

SELL
$310.63 - $364.82 $863,551 - $1.01 Million
-2,780 Reduced 16.49%
14,076 $4.83 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $17.3 Million - $20.2 Million
-53,808 Reduced 76.15%
16,856 $6.17 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $9.49 Million - $10.8 Million
32,000 Added 82.76%
70,664 $22.8 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $18.7 Million - $21.9 Million
-67,003 Reduced 63.41%
38,664 $12.5 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $14.2 Million - $17.6 Million
60,377 Added 133.31%
105,667 $30.3 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $6.84 Million - $8.49 Million
30,412 Added 204.41%
45,290 $12.5 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $758,315 - $933,213
-3,422 Reduced 18.7%
14,878 $3.44 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $11.8 Million - $15.3 Million
-65,550 Reduced 78.18%
18,300 $4.2 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $9.29 Million - $12 Million
56,515 Added 206.75%
83,850 $15.7 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $1.75 Million - $2.31 Million
13,388 Added 95.99%
27,335 $4.62 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $184,529 - $213,442
1,262 Added 9.95%
13,947 $2.06 Million
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $1.62 Million - $1.95 Million
11,885 Added 1485.63%
12,685 $2.08 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $85,596 - $105,944
-719 Reduced 47.33%
800 $111,000
Q4 2019

Feb 07, 2020

SELL
$106.92 - $132.43 $1.21 Million - $1.49 Million
-11,276 Reduced 88.13%
1,519 $200,000
Q3 2019

Nov 05, 2019

BUY
$106.79 - $116.16 $1.37 Million - $1.49 Million
12,795 New
12,795 $1.43 Million
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $1.46 Million - $1.71 Million
-13,192 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $1.91 Million - $2.25 Million
-17,170 Reduced 56.55%
13,192 $1.71 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $2.27 Million - $2.54 Million
21,430 Added 239.92%
30,362 $3.51 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $1.76 Million - $2.2 Million
-20,513 Reduced 69.67%
8,932 $958,000
Q2 2018

Aug 15, 2018

BUY
$75.7 - $86.88 $2.23 Million - $2.56 Million
29,445 New
29,445 $2.51 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $229,383 - $270,771
-3,091 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$81.94 - $87.89 $217,550 - $233,347
2,655 Added 608.94%
3,091 $261,000
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $33,602 - $37,295
436
436 $37,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.